Ellen Oostenbach
- Immunotherapy and Immune Responses
- Monoclonal and Polyclonal Antibodies Research
- Cancer Immunotherapy and Biomarkers
- vaccines and immunoinformatics approaches
Princess Máxima Center
2024
Identification of immunogenic cancer neoantigens as targets for therapy is challenging. Here, we integrate the whole-genome and long-read transcript sequencing cancers to identify collection neo-open reading frame peptides (NOP) expressed in tumors. We termed this NOPs tumor framome. represent tumor-specific that are different from wild-type proteins may be strongly immunogenic. describe a class hidden derive structural genomic variants involving an upstream protein coding gene driving...
<p>Figure S10: A) NOP expression compared to normal genes.</p>
<p>Figure S15: Tetramer gating strategy.</p>
<p>Figure S7: Protein mass spectrometry results for A375 NOPs.</p>
<p>Figure S16: Expansion of FRM-specific CD8T cells after priming with relevant peptide in PBMC from healthy individuals.</p>
<p>Figure S14: A375 immunopeptidomics.</p>
<p>Figure S1: RNA-guided tumor genome reconstruction.</p>
<p>Figure S4: Overview of somatic mutation statistics for tumor samples analyzed by WGS in this study.</p>
<p>Figure S16: Expansion of FRM-specific CD8T cells after priming with relevant peptide in PBMC from healthy individuals.</p>
<p>Figure S8: Comparison of EasyFuse short-read fusion gene caller with long-read and WGS guided NOP identification.</p>
<p>Figure S11: Example of a hidden NOP resulting from complex chromosomal rearrangement in tumor sample LUN022.</p>
<p>Figure S13: In silico determined immunogenic properties of NOPs.</p>
<p>Figure S8: Comparison of EasyFuse short-read fusion gene caller with long-read and WGS guided NOP identification.</p>
<div>Abstract<p>Identification of immunogenic cancer neoantigens as targets for therapy is challenging. Here, we integrate the whole-genome and long-read transcript sequencing cancers to identify collection neo-open reading frame peptides (NOP) expressed in tumors. We termed this NOPs tumor framome. represent tumor-specific that are different from wild-type proteins may be strongly immunogenic. describe a class hidden derive structural genomic variants involving an upstream...
<p>Figure S5: Long-read transcript sequencing statistics.</p>
<p>Figure S7: Protein mass spectrometry results for A375 NOPs.</p>
<p>Figure S11: Example of a hidden NOP resulting from complex chromosomal rearrangement in tumor sample LUN022.</p>
<p>Figure S6: Comparison of long and short read RNA gene expression quantification transcript coverage bias.</p>
<p>Figure S1: RNA-guided tumor genome reconstruction.</p>
<div>Abstract<p>Identification of immunogenic cancer neoantigens as targets for therapy is challenging. Here, we integrate the whole-genome and long-read transcript sequencing cancers to identify collection neo-open reading frame peptides (NOP) expressed in tumors. We termed this NOPs tumor framome. represent tumor-specific that are different from wild-type proteins may be strongly immunogenic. describe a class hidden derive structural genomic variants involving an upstream...
<p>Figure S13: In silico determined immunogenic properties of NOPs.</p>
<p>Figure S5: Long-read transcript sequencing statistics.</p>
<p>Figure S9: Results of NOP identification using simulated sequencing data.</p>